Regulation 66 Amendment of regulation 60 (conditions of UK marketing authorisation: exceptional circumstances)I1F1
United Kingdom
In regulation 60—
after “UK marketing authorisation” in each place it occurs (including the heading to the regulation) insert “or parallel import licence”;
after “the authorisation” in each place it occurs insert “or licence”;
in paragraph (3), after “an authorisation” insert “or licence”;
for paragraph (9) substitute—
“(9)The licensing authority must notify the EMA of any UKMA(NI) or UKMA(UK) that it has granted subject to a condition included in accordance with this regulation.”;
in paragraph (10), after “a marketing authorisation” insert “or licence”.
Annotations
Textual amendments
- F1
Reg. 66 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 49
Commencement
- I1
Reg. 66 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1